
Laurus Labs share price climbed nearly 6% to a record high of ₹2,381.15 on Friday after reporting strong September-quarter financial results.
The company's net profit surged 126% year-on-year to ₹441 crore, while revenue rose 33% to ₹2,206 crore for the second quarter of FY27.
Laurus Labs also declared an interim dividend of Re 1 per share, driven by growth in its CDMO business and Affordable Medicines division.